No abstract available
MeSH terms
-
Adenosine Monophosphate / administration & dosage
-
Adenosine Monophosphate / analogs & derivatives*
-
Aged
-
Coronary Artery Disease / therapy*
-
Drug Approval*
-
Female
-
Humans
-
Injections, Intravenous
-
Intraoperative Period
-
Male
-
Middle Aged
-
Percutaneous Coronary Intervention*
-
Purinergic P2Y Receptor Antagonists / administration & dosage
-
Randomized Controlled Trials as Topic*
-
Tertiary Care Centers*
-
United States
-
United States Food and Drug Administration
Substances
-
Purinergic P2Y Receptor Antagonists
-
Adenosine Monophosphate
-
cangrelor